Vivace Therapeutics: Funding, Investors & Team (Oct 2026)
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. At Vivace Therapeutics, they pursue their work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused portfolio-based drug discovery and development company adopting a capital-efficient and modality-indifferent approach to bring novel therapies to patients in need. Their experienced management team and world-class scientists work to advance promising drugs and therapeutic technologies that they believe can help conquer cancer.
Vivace Therapeutics has raised $65.0M across 2 funding rounds on record, the most recent a Series D of $35.0M announced in Mar 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vivace Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Vivace Therapeutics Funding Rounds
Vivace Therapeutics raised $30.0M in an undisclosed round announced in Dec 2020.
4.3 years later, a Series D of $35.0M was announced in Mar 2025.
Vivace Therapeutics Founders and Leadership Team
Contact details for the Vivace Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Vivace Therapeutics Funding Compared to Other Biotechnology Startups
Vivace Therapeutics' latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vivace Therapeutics in Biotechnology and San Mateo
Companies Similar to Vivace Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Vivace Therapeutics Funding FAQs
What does Vivace Therapeutics do?
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. At Vivace Therapeutics, they pursue their work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused portfolio-based drug discovery and development company adopting a capital-efficient and modality-indifferent approach to bring novel therapies to patients in need. Their experienced management team and world-class scientists work to advance promising drugs and therapeutic technologies that they believe can help conquer cancer.
How much funding has Vivace Therapeutics raised?
Vivace Therapeutics has raised $65.0M across 2 rounds on record. The most recent is a Series D of $35.0M announced in Mar 2025.
When did Vivace Therapeutics last raise funding?
Vivace Therapeutics' most recent funding round on record is a Series D of $35.0M, announced in Mar 2025.
Who founded Vivace Therapeutics?
FundedIQ lists Sofie Qiao (Founder) at Vivace Therapeutics.
Where is Vivace Therapeutics headquartered?
Vivace Therapeutics is based in San Mateo, California, United States.
How many employees does Vivace Therapeutics have?
Vivace Therapeutics is in the 11-50 employee band.
How does Vivace Therapeutics' funding compare to other Biotechnology startups?
Vivace Therapeutics' latest round of $35.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Vivace Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vivace Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.